Target Name: FSCB
NCBI ID: G84075
Review Report on FSCB Target / Biomarker Content of Review Report on FSCB Target / Biomarker
FSCB
Other Name(s): Fibrous sheath CABYR binding protein | fibrous sheath CABYR binding protein | DKFZp434F1017 | DKFZp686J0539 | C14orf155 | FSCB_HUMAN | DKFZp686A1639 | Fibrous sheath CABYR-binding protein

Function and function of Fibrous Sheath CABYR Binding Protein (FSCB)

Fibrous sheath CABYR binding protein (FSCB) is a protein that is expressed in various tissues throughout the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the CABYR family of proteins, which are involved in the assembly and disassembly of actin filaments. FSCB is unique among these proteins because it is able to bind specifically to the fibrous sheath of actin filaments, which are a type of protein that helps to keep actin filaments in a fixed state.

FSCB has been shown to play a role in many different processes in the body, including the regulation of cell growth, the development of tissues, and the response to stimuli. It is also a potential drug target, which means that scientists are studying its potential to be used as a treatment for a variety of diseases.

One of the ways that FSCB is involved in these processes is by regulating the formation of new actin filaments. Actin filaments are made up of a protein called actinin, which is a key component of the cytoskeleton. FSCB is able to bind to actinin and prevent it from being removed from the actin filament, which allows the filament to continue growing and the cell to continue dividing.

Another way that FSCB is involved in the regulation of cell growth is by preventing the formation of new blood vessels. When a cell needs to grow, it needs to receive oxygen and nutrients from the surrounding environment. FSCB is able to bind to the endothelial cell, which is the cell that forms the lining of the blood vessels. This causes FSCB to prevent the formation of new endothelial cells, which helps to keep the blood vessels from growing too thick.

FSCB is also involved in the development of tissues. During development, cells need to be organized into specific types and structures in order to develop into the various tissues of the body. FSCB is able to interact with other proteins that are involved in this process, including the transcription factor SOX-9. This allows FSCB to help ensure that the correct types of cells are developed and that they are properly organized into the tissues.

Finally, FSCB is involved in the response to stimuli, including the sensation of touch. When a touch is applied to a surface, the cells that make up that surface respond by expanding or contracting. FSCB is able to interact with the protein F-actin, which is involved in this process. This allows FSCB to help regulate the size of the cells that respond to the touch.

In conclusion, FSCB is a protein that is involved in a variety of processes in the body, including the regulation of cell growth, the development of tissues, and the response to stimuli. It is also a potential drug target, which means that scientists are studying its potential to be used as a treatment for a variety of diseases. Further research is needed to fully understand the role of FSCB in these processes and to develop effective treatments.

Protein Name: Fibrous Sheath CABYR Binding Protein

Functions: May be involved in the later stages of fibrous sheath biogenesis and spermatozoa capacitation. Inhibits ROPN1 and ROPN1L SUMOylation. Binds calcium

The "FSCB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FSCB comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FSCN1 | FSCN2 | FSCN3 | FSD1 | FSD1L | FSD2 | FSHB | FSHR | FSIP1 | FSIP2 | FSIP2-AS2 | FST | FSTL1 | FSTL3 | FSTL4 | FSTL5 | FTCD | FTCDNL1 | FTH1 | FTH1P1 | FTH1P10 | FTH1P11 | FTH1P12 | FTH1P2 | FTH1P20 | FTH1P22 | FTH1P24 | FTH1P3 | FTH1P4 | FTH1P5 | FTH1P7 | FTH1P8 | FTHL17 | FTL | FTLP16 | FTLP2 | FTLP3 | FTLP7 | FTMT | FTO | FTO-IT1 | FTOP1 | FTSJ1 | FTSJ3 | FTX | FUBP1 | FUBP3 | FUCA1 | FUCA2 | Fucosyl GM1 | Fucosyltransferase | FUNDC1 | FUNDC2 | FUNDC2P2 | FUNDC2P3 | FUOM | FURIN | FUS | FUT1 | FUT10 | FUT11 | FUT2 | FUT3 | FUT4 | FUT5 | FUT6 | FUT7 | FUT8 | FUT8-AS1 | FUT9 | FUZ | FXN | FXR1 | FXR2 | FXYD1 | FXYD2 | FXYD3 | FXYD4 | FXYD5 | FXYD6 | FXYD6-FXYD2 | FXYD7 | FYB1 | FYB2 | FYCO1 | FYN | FYTTD1 | FZD1 | FZD10 | FZD10-AS1 | FZD2 | FZD3 | FZD4 | FZD4-DT | FZD5 | FZD6 | FZD7 | FZD8 | FZD9 | FZR1